SABR irradiation could induce the proliferation of tumor‐responsive PD‐1+CD11ahighCD8+ T cells in irradiated sites and drainage lymphoid tissues, and PD‐1 blockade could improve their antitumor immunity. Here, PDCD1 is linked to neoplasm.